Medical Devices & Diagnostics
Medical devices and diagnostics are the hardware of medicine — implants, surgical robots, imaging, and the tests that decide what treatment follows. Approval and reimbursement matter to the investment case as much as the technology does.
342 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 26 |
Invesco
Atlanta,
Georgia
| $6.55B | +$216M | 89 | 2.04% | Increased |
|
| 27 |
Legal & General Group
London,
United Kingdom
| $5.87B | +$137M | 104 | 4.74% | Increased |
|
| 28 |
American Century Companies
Kansas City,
Missouri
| $5.84B | -$314M | 48 | 6.04% | Reduced |
|
| 29 |
Primecap Management
Pasadena,
California
| $5.66B | -$83.7M | 21 | 4.86% | Reduced |
|
| 30 |
Charles Schwab
San Francisco,
California
| $4.85B | +$170M | 103 | 4.56% | Increased |
|
| 31 |
Swiss National Bank
Zurich,
Switzerland
| $4.84B | +$171M | 86 | 5.74% | Increased |
|
| 32 |
Artisan Partners
Milwaukee,
Wisconsin
| $4.79B | -$150M | 13 | 8.99% | Reduced |
|
| 33 |
Royal Bank of Canada
Toronto,
Ontario, Canada
| $4.7B | +$130M | 125 | 2.43% | Increased |
|
| 34 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $4.64B | -$360M | 130 | 3.31% | Reduced |
|
| 35 |
UBS AM
Chicago,
Illinois
| $4.56B | +$80.2M | 76 | 4.42% | Increased |
|
| 36 |
Principal Financial Group
Des Moines,
Iowa
| $4.52B | +$772M | 77 | 4.53% | Increased |
|
| 37 |
UBS Group
Zurich,
Switzerland
| $4.31B | +$519M | 140 | 2.23% | Increased |
|
| 38 |
Boston Partners
Boston,
Massachusetts
| $4.13B | -$447M | 18 | 5.25% | Reduced |
|
| 39 |
New York State Common Retirement Fund
Albany,
New York
| $3.86B | +$82.4M | 103 | 5.09% | Increased |
|
| 40 |
Third Point
New York
| $3.77B | -$248M | 3 | 33.41% | Reduced |
|
| 41 |
Barrow, Hanley, Mewhinney & Strauss
Dallas,
Texas
| $3.7B | -$102M | 9 | 5.62% | Reduced |
|
| 42 |
Renaissance Technologies
New York
| $3.56B | -$192M | 104 | 4.55% | Reduced |
|
| 43 |
Greenleaf Trust
Kalamazoo,
Michigan
| $3.4B | -$101M | 15 | 77.67% | Reduced |
|
| 44 |
Macquarie Group
Sydney, NSW 2000,
Australia
| $3.4B | -$236M | 54 | 6.21% | Reduced |
|
| 45 |
Neuberger Berman Group
New York
| $3.36B | -$74.1M | 58 | 4.32% | Reduced |
|
| 46 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
| $3.28B | -$304M | 9 | 4.42% | Reduced |
|
| 47 |
Parametric Portfolio Associates
Seattle,
Washington
| $3.26B | +$802M | 94 | 3.9% | Increased |
|
| 48 |
Teachers Advisors
New York
| $3.13B | +$89.8M | 102 | 4.39% | Increased |
|
| 49 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
| $3B | +$63M | 25 | 4.4% | Increased |
|
| 50 |
Lazard Asset Management
New York
| $2.94B | +$510M | 24 | 5.53% | Increased |
|